Integrating data for disease prediction
The OActive project intends to make a significant leap forward in the fight of this disease by adopting a multi-scale holistic approach where patient-specific information from various levels, including cell, tissue, organ and whole body will be integrated and combined with information from other sources, such as biochemical/inflammatory biomarkers, behaviour modeling and social/environmental risk factors.
This will help generate robust predictors for new personalised interventions for delaying onset and slowing down the progression of OA.
To overcome the limitation of the current treatment interventions, Augmented Reality empowered interventions will be developed in a personalised framework, allowing patients experience the treatment as more enjoyable, resulting in greater motivation, engagement, and training adherence.
The OActive partners have four years to improve healthcare by transforming and accelerating OA diagnosis and prediction. The consortium integrates research groups, universities and companies from Belgium, Cyprus, Germany, Greece, Italy, Spain and United Kingdom.
This project was awarded a budget of maximum € 4,984,033.75 under the framework program for research and innovation Horizon 2020.
Osteoarthritis (OA) is a degenerative disease of the articular cartilage. It is the most common form of arthritis and causes joint pain, mobility limitation and, thus, reduces independence and overall the quality of life. Although the usual population associated with the condition is over 65 years old, athletes and younger individuals are also susceptible.